Key Statistics for TARO
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (03/2014)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for TARO
- Net Income (M/USD)
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company that discovers, develops, manufactures, and markets healthcare products. The Company's products include prescription and over-the-counter drugs.
More Company Profile & Key Executives for TARO
|Dilip Shantilal ShanghviChairman||Kalyanasundaram Subramanian "Kal"Chief Executive Officer|
|Michael Perfetto Chief Commercial Ofcr:Generic RX||Sunil MehtaVP/General Manager|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.